Study at Cambridge
About the University
Research at Cambridge
Mobile menu
Mobile menu
Privacy
Cookies
Accessibility
Search
About
About
Our team
Our performance
Careers
The Cambridge ecosystem
Partnerships and collaboration
back
For the University
For the University
Tell us your idea
Be a consultant
Develop a commercial opportunity
Start a company or social venture
Develop your skills & network
Cambridge Enterprise Academic Portal
back
For external organisations
For external organisations
Find a consultant
Opportunities to invest
International outreach
Available technologies
Available research tools
Experts & Mentors Programme
back
Latest
Latest
News
Insights
Case studies
Videos
back
What’s on
Contact us
Posts Tagged ‘biotechnology’
biotechnology
Share:
Life Sciences
18 December 2018
Spin-out Morphogen-IX raises £18.4m in a Series B financing
Find out more
Cambridge Innovation Capital
27 November 2018
Spin-out Morphogen-IX announces its clinical development candidate
Find out more
Life Sciences
1 November 2018
Seed Fund Investment Manager on BioBeat’s 2018 list of 50 Female Movers and Shakers
Find out more
Life Sciences
15 December 2016
Cambridge Enterprise licenses IP to produce platelets from stem cells
Find out more
Life Sciences
23 January 2014
Holographic diagnostics developed to monitor medical conditions
Find out more
Life Sciences
10 June 2013
Clearing the BAR to oral vaccines
Find out more
Life Sciences
19 July 2012
Commercialising medical device innovation
Find out more
Life Sciences
22 March 2012
New programme to help Cambridge researchers connect with industry
Find out more
Physical Sciences
22 February 2011
TeraView strengthens relationship with Cambridge University
Find out more
Life Sciences
4 February 2011
Cambridge spin-outs recognised at European entrepreneurship awards
Find out more
Life Sciences
12 January 2011
Astex announces milestone in oncology collaboration
Find out more
Cambridge Enterprise
24 March 2010
Highly successful year for Cambridge Enterprise
Find out more
1
2
Sign up to our newsletter
Stay in touch with the latest updates from Cambridge Enterprise
Sign up now